|
1
|
Duyuler PT, Duyuler S and Demir M: Impact
of myocardial blush grade on Tpe interval and Tpe/QT ratio after
successful primary percutaneous coronary intervention in patients
with ST elevation myocardial infarction. Eur Rev Med Pharmacol Sci.
21:143–149. 2017.PubMed/NCBI
|
|
2
|
Lu Y, Li Y, Yao R, Li Y, Li L, Zhao L and
Zhang Y: Clinical effect of ticagrelor administered in acute
coronary syndrome patients following percutaneous coronary
intervention. Exp Ther Med. 11:2177–2184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lago IM, Marin-Neto JA, Lima-Filho MDO,
Filho AP, Figueiredo GL, Haddad JL, Botelho R, Barbosa R,
Gianechini UM and Siqueira BD: Does the inhibition of the final
common pathway of platelet aggregation reduce the no-reflow
phenomenon during primary percutaneous coronary intervention?
Tirofiban no Infarto Agudo do miocárdio e a não Reperfusão (TIARA).
Rev Bras Cardiol Invasiva. 22:81–86. 2014.http://www.sciencedirect.com/science/article/pii/S2214123515301836May
7–2016 View Article : Google Scholar
|
|
4
|
Celik T, Balta S, Ozturk C, Kaya MG,
Aparci M, Yildirim OA, Demir M, Unlu M, Demirkol S, Kilic S, et al:
Predictors of No-Reflow phenomenon in young patients with acute
ST-Segment elevation myocardial infarction undergoing primary
percutaneous coronary intervention. Angiology. 67:683–689. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cetin M, Kiziltunc E, Güven Cetin Z, Kundi
H, Gulkan B and Cicekcioglu H: A practical method for No-Reflow
treatment. Case Rep Cardiol. 2016:95961232016.PubMed/NCBI
|
|
6
|
Modolo R, Figueiredo VN, Moura FA, Almeida
B, Quinaglia e Silva JC, Nadruz W Jr, Lemos PA, Coelho OR, Blaha MJ
and Sposito AC; Brasilia Heart Study Group, : Coronary artery
calcification score is an independent predictor of the no-reflow
phenomenon after reperfusion therapy in acute myocardial
infarction. Coron Artery Dis. 26:562–566. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu N, Hou M, Ren W, Cao J, Wu H and Zhou
W: Clinical research of treatment with tirofiban for high-risk
non-ST-segment elevation acute coronary syndrome during
peri-operative intervention operation period. Cell Biochem Biophys.
71:43–47. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carden DL and Granger DN: Pathophysiology
of ischaemia-reperfusion injury. J Pathol. 190:255–266. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jaeschke H: Molecular mechanisms of
hepatic ischemia-reperfusion injury and preconditioning. Am J
Physiol Gastrointest Liver Physiol. 284:G15–26. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dong M, Mu N, Ren F, Sun X, Li F, Zhang C
and Yang J: Prospective study of effects of endogenous estrogens on
myocardial no-reflow risk in postmenopausal women with acute
myocardial infarction. J Interv Cardiol. 27:437–443. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Herring MJ, Dai W, Hale SL and Kloner RA:
Rapid induction of hypothermia by the ThermoSuit system profoundly
reduces infarct size and anatomic zone of no reflow following
ischemia-reperfusion in rabbit and rat hearts. J Cardiovasc
Pharmacol Ther. 20:193–202. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kurtul A, Ocek AH, Murat SN, Yarlioglues
M, Demircelik MB, Duran M, Ergun G and Cay S: Serum albumin levels
on admission are associated with angiographic no-reflow after
primary percutaneous coronary intervention in patients with
ST-segment elevation myocardial infarction. Angiology. 66:278–285.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou SS, Tian F, Chen YD, Wang J, Sun ZJ,
Guo J and Jin QH: Combination therapy reduces the incidence of
no-reflow after primary per-cutaneous coronary intervention in
patients with ST-segment elevation acute myocardial infarction. J
Geriatr Cardiol. 12:135–142. 2015.PubMed/NCBI
|
|
14
|
Dong M, Mu N, Ren F, Li F, Zhang C and
Yang J: Matrix metalloproteinase-9 in the culprit coronary artery
and myocardial No-Reflow. Am J Med Sci. 350:352–356. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pereira LH, Machado JR, Olegario JG, Rocha
LP, Silva MV, Guimaraes CS, Reis MA, Castellano LR, Ramalho FS and
Correa RR: Interleukin-6 and C-reactive protein are overexpressed
in the liver of perinatal deaths diagnosed with fetal inflammatory
response syndrome. Dis Markers 2014. 2527802014.doi:
10.1155/2014/252780.
|
|
16
|
Daidoji H, Takahashi H, Otaki Y, Tamura H,
Arimoto T, Shishido T, Miyashita T, Miyamoto T, Watanabe T and
Kubota I: A combination of plaque components analyzed by integrated
backscatter intravascular ultrasound and serum pregnancy-associated
plasma protein a levels predict the no-reflow phenomenon during
percutaneous coronary intervention. Catheter Cardiovasc Interv.
85:43–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Calabro P, Golia E and Yeh ET: CRP and the
risk of atherosclerotic events. Semin Immunopathol. 31:79–94. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Delewi R, Nijveldt R, Hirsch A, Marcu CB,
Robbers L, Hassell ME, de Bruin RH, Vleugels J, van der Laan AM,
Bouma BJ, et al: Left ventricular thrombus formation after acute
myocardial infarction as assessed by cardiovascular magnetic
resonance imaging. Eur J Radiol. 81:3900–3904. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang HJ, Rozanski GJ and Zucker IH:
Cardiac sympathetic afferent reflex control of cardiac function in
normal and chronic heart failure states. J Physiol. 595:2519–2534.
2017. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lindner E and Ruppert D: Effects of
calcium antagonists on coronary spasm and pulmonary artery
contraction in comparison to their antagonistic action against
K-strophanthin in isolated guinea pig atria. Pharmacology.
24:294–302. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shapira OM, Alkon JD, Macron DS, Keaney JF
Jr, Vita JA, Aldea GS and Shemin RJ: Nitroglycerin is preferable to
diltiazem for prevention of coronary bypass conduit spasm. Ann
Thorac Surg. 70:883–889. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Birnbaum Y, Atar S, Luo H, Nagai T and
Siegel RJ: Ultrasound has synergistic effects in vitro with
tirofiban and heparin for thrombus dissolution. Thromb Res.
96:451–458. 1999. View Article : Google Scholar : PubMed/NCBI
|
